Literature DB >> 10771477

Reduced hyaluronan in keloid tissue and cultured keloid fibroblasts.

L J Meyer1, S B Russell, J D Russell, J S Trupin, B M Egbert, S Shuster, R Stern.   

Abstract

Extracellular matrix hyaluronan is prominent during wound healing, appearing at elevated levels early in the repair process. It is prevalent throughout the course of fetal wound healing, which is scar-free, but decreases late in adult wound repair, that is often marked by scarring. To determine whether aberrant hyaluronan metabolism is associated with the excessive scarring that characterizes keloids, cultured fibroblasts derived from keloids and from the dermis of normal human skin and scar were compared. Levels of hyaluronan in 48 h conditioned media of keloid-derived cultures were significantly lower than in cultures of normal skin and scar fibroblasts. Profiles of hyaluronan polymer size were comparable in these two cell types, suggesting that excessive hyaluronan degradation was not involved. Hydrocortisone decreased hyaluronan levels approximately 70% in the conditioned media of both keloid and normal fibroblasts. Diminished hyaluronan accumulation in keloid-derived cells compared with normal fibroblasts was also observed in an in vitro wound healing model. Histolocalization of hyaluronan in keloids, normal skin, and scar samples confirmed the biochemical observations that the dermis of keloids, which comprises most of the scar tissue, contained markedly diminished levels of hyaluronan. Alterations in hyaluronan in the epidermis overlying keloids, however, were also observed. A modest increase in hyaluronan staining intensity was observed in the epidermis of keloids, as well as changes in the patterns of distribution within the epidermis, compared with that in normal skin and scar. Increased hyaluronan was present in the granular and spinous layers of the keloid epidermis Abnormalities are present apparently in both the overlying epidermis as well as in the dermis of keloids. Aberrations in signaling between keloid stroma and keloid epidermis may underlie abnormalities that contribute to the excessive fibrosis characteristic of these lesions.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10771477     DOI: 10.1046/j.1523-1747.2000.00950.x

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  17 in total

1.  Gene profiling of keloid fibroblasts shows altered expression in multiple fibrosis-associated pathways.

Authors:  Joan C Smith; Braden E Boone; Susan R Opalenik; Scott M Williams; Shirley B Russell
Journal:  J Invest Dermatol       Date:  2007-11-08       Impact factor: 8.551

2.  The potential of a niacinamide dominated cosmeceutical formulation on fibroblast activity and wound healing in vitro.

Authors:  Quenton Wessels; Etheresia Pretorius; Celeste M Smith; Hugo Nel
Journal:  Int Wound J       Date:  2012-08-14       Impact factor: 3.315

3.  Epigenetically altered wound healing in keloid fibroblasts.

Authors:  Shirley B Russell; James D Russell; Kathryn M Trupin; Angela E Gayden; Susan R Opalenik; Lillian B Nanney; Alan H Broquist; Latha Raju; Scott M Williams
Journal:  J Invest Dermatol       Date:  2010-06-17       Impact factor: 8.551

4.  Role of Hyaluronic Acid Treatment in the Prevention of Keloid Scarring.

Authors:  Andrea Hoffmann; Jessica Lynn Hoing; Mackenzie Newman; Richard Simman
Journal:  J Am Coll Clin Wound Spec       Date:  2013-07-01

5.  Adenoviral overexpression and small interfering RNA suppression demonstrate that plasminogen activator inhibitor-1 produces elevated collagen accumulation in normal and keloid fibroblasts.

Authors:  Tai-Lan Tuan; Paul Hwu; Wendy Ho; Peter Yiu; Richard Chang; Annette Wysocki; Paul D Benya
Journal:  Am J Pathol       Date:  2008-10-02       Impact factor: 4.307

6.  Transcriptional profiling of rapamycin-treated fibroblasts from hypertrophic and keloid scars.

Authors:  Victor W Wong; Fanglei You; Michael Januszyk; Geoffrey C Gurtner; Anna A Kuang
Journal:  Ann Plast Surg       Date:  2014       Impact factor: 1.539

7.  MicroRNA-143-3p inhibits hyperplastic scar formation by targeting connective tissue growth factor CTGF/CCN2 via the Akt/mTOR pathway.

Authors:  Shengzhi Mu; Bei Kang; Weihui Zeng; Yaowen Sun; Fan Yang
Journal:  Mol Cell Biochem       Date:  2016-04-13       Impact factor: 3.396

8.  Characterization of hyaluronan and TSG-6 in skin scarring: differential distribution in keloid scars, normal scars and unscarred skin.

Authors:  K T Tan; D A McGrouther; A J Day; C M Milner; A Bayat
Journal:  J Eur Acad Dermatol Venereol       Date:  2011-03       Impact factor: 6.166

Review 9.  Marine polysaccharides: a source of bioactive molecules for cell therapy and tissue engineering.

Authors:  Karim Senni; Jessica Pereira; Farida Gueniche; Christine Delbarre-Ladrat; Corinne Sinquin; Jacqueline Ratiskol; Gaston Godeau; Anne-Marie Fischer; Dominique Helley; Sylvia Colliec-Jouault
Journal:  Mar Drugs       Date:  2011-09-23       Impact factor: 6.085

10.  Unusual glycosaminoglycans from a deep sea hydrothermal bacterium improve fibrillar collagen structuring and fibroblast activities in engineered connective tissues.

Authors:  Karim Senni; Farida Gueniche; Sylvie Changotade; Dominique Septier; Corinne Sinquin; Jacqueline Ratiskol; Didier Lutomski; Gaston Godeau; Jean Guezennec; Sylvia Colliec-Jouault
Journal:  Mar Drugs       Date:  2013-04-23       Impact factor: 5.118

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.